The study is to evaluate the product reliability, therapy effectiveness and user feedback of a Continuous Positive Airway Pressure (CPAP) device in-home for up to 6 months.

Existing and Naïve CPAP users will be recruited into a 6 month in-home study Participants will attend 5 study visits at day 0, 7, 30, 60 and 180. Outcome of the clinical investigation include downloadable device data reports, device error reports and participants perception questionnaires.

Inclusion Criteria:

• Aged 22 and over
• Diagnosed with Obstructive Sleep Apnea (OSA) and prescribed Positive Airway Pressure (either Continuous positive airway pressure (CPAP) or AutoCPAP)
• For experienced users of PAP (CPAP or AutoCPAP) - you must be using PAP of more than 4 hours/night for 70% during the last 30 days.

Exclusion Criteria:

• Contraindicated for PAP (CPAP or AutoCPAP) therapy
• Has other significant sleep disorders (e.g periodic leg movements, insomnia, central sleep apnea)
• Has obesity hypoventilation syndrome or congestive heart failure
• Requires supplemental oxygen with their PAP (CPAP or AutoCPAP) device
• Has implanted electronic medical devices (e.g cardiac pacemakers)
• Pregnant or think they may be pregnant
• Not fluent in spoken and written English.

Adverse events were collected during the study period of each participant (i.e. 6 months)